RegASK, a global RegTech SaaS company, today announced it has raised a $10m Series A funding round. The round is led by venture capital firm Monograph Capital and joined by SPRIM Global Investments and other investors. The funding will be used to further invest in the platform and bring RegASK to all companies seeking to strengthen their regulatory capabilities around the globe. The funding follows on the heels of the expansion of RegASK platform to serve new industries including biopharma and decentralized clinical trials regulation, in addition to the existing deployment in consumer health, medtech, and food industries.
Who to call at RegASK, and when
A new round usually means RegASK is about to hire and buy. The teams that reach out first get the meeting.
An alert the day RegASK raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at RegASK, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
RegASK
Location
Singapore, Southeast Asia, Singapore
About
RegASK is a leading agentic AI regulatory intelligence and workflow orchestration platform that empowers global organizations in highly regulated sectors, including consumer products and life sciences, to proactively navigate complex regulatory landscapes. By combining advanced Agentic AI with experts in the loop, RegASK delivers real-time, actionable insights and end-to-end automation, streamlining compliance processes, mitigating risks, and accelerating market access across more than 140 countries.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RegASK raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.